ArticleJournal of cellular and molecular medicine2021

Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification.

Xuling Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.